Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Reduning
TCM
Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021
Qing Fei Pai Du Tang
TCM
Potential treatment - clinical evidence Natural product Antiviral Feb/28/2021
Oroxylin A
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/15/2021
Yindan Jiedu
TCM
Potential treatment - clinical evidence Natural product Antiviral Feb/05/2021
Lianhua Qingwen
TCM
Recommended by China's NHC Guidelines Natural product Other treatment Jan/29/2021
4-(3-Phenylacryloyloxymethyl)-6,7-dimethoxycoumarin
TCM
Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021
Quercetagetin
TCM
Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021
Xuanfei Baidu decoction
TCM
Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
Neochlorogenic acid
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythoside I
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythiaside
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Rhein
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Mahuang Liu Jun Tang
TCM
Potential treatment - clinical evidence Natural product Unknown Sep/14/2020
Xue Bi Jing
TCM
Potential treatment - clinical evidence Natural product Other treatment Sep/10/2020
Andrographolide
TCM
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/25/2020